The study revealed that valuable and consistent discrimination of sepsis and septic shock was achieved by measurements of PTX-3 plasma levels during days 1, 3, and 8 of ICU treatment, specifically for the presence of at least sepsis. This evidence concerns the gene PTX3 and Sepsis.